CABERGOLINE

Generic: CABERGOLINE

Amneal Pharmaceuticals NY LLCManufacturer
ORALRoute
CABERGOLINEActive Substance
2024-06-25Original Approval

CABERGOLINE is FDA application ANDA218618, sponsored by AMNEAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class III2012-04-24
CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 1896

Impurities/Degradation Products: This lot of product will not meet the impurity specification over s

Top Reported Reactions

1
DRUG INEFFECTIVE
399 reports
2
OFF LABEL USE
386 reports
3
HEADACHE
339 reports
4
FATIGUE
285 reports
5
NAUSEA
279 reports
6
DIZZINESS
228 reports
7
MALAISE
214 reports
8
PAIN
199 reports
9
DIARRHOEA
181 reports
10
RASH
177 reports